Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Adicet Bio
Biotech
Adicet's gamma delta CAR-T therapy readout tees up phase 2 trial
Adicet Bio’s gamble on the nascent gamma delta CAR-T cell therapy space seems to be paying off.
James Waldron
Jun 6, 2022 11:14am
Adicet soars on early responses to gamma delta CAR-T therapy
Dec 6, 2021 8:30am
Adicet inks resTORbio reverse merger, plots financing
Apr 30, 2020 8:00am
Adicet Bio reels in $80M to push lymphoma program into clinic
Oct 3, 2019 7:15am
Chutes & Ladders—Parexel co-founder ends 35-year run as CEO
Mar 9, 2018 8:15am
Adicet CEO retires, leaving interim leader in charge
Mar 6, 2018 9:25am
